Benzinga Rankings give you vital metrics on any stock – anytime.
Explore XTL Biopharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XTLB.
You can purchase shares of XTL Biopharmaceuticals (NASDAQ:XTLB) through any online brokerage.
Other companies in XTL Biopharmaceuticals’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS) and Cellectar Biosciences (NASDAQ:CLRB).
There is no analysis for XTL Biopharmaceuticals to provide a consensus price target.
The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $1.1 last updated May 20, 2025 at 12:44 PM EDT.
There are no upcoming dividends for XTL Biopharmaceuticals.
XTL Biopharmaceuticals’s Q1 earnings are confirmed for Tuesday, August 19, 2025.
There is no upcoming split for XTL Biopharmaceuticals.
XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.